Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus

Journal of Association of Physicians of India

Volumn 57, Issue 3, 2009, Pages 205-210

  Prashanth, M ^a   Ganesh, H K ^a   Vimal, M V ^a   John, M ^a   Bandgar, T ^a   Joshi, Shashank R ^a   Shah, S R ^c   Rathi, P M ^a   Joshi, A S ^a   Thakkar, Hemangini ^b   Menon, P S ^a   Shah, N S ^a  

^a Department of Endocrinology ^*

^b KEM HOSPITAL   (India)

^c JASLOK HOSPITAL AND RESEARCH CENTRE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COHORT ANALYSIS; FATTY LIVER; FEMALE; HEPATITIS; HUMAN; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; RISK FACTOR;

ADULT; AGED; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FATTY LIVER; FEMALE; HEPATITIS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; YOUNG ADULT;

EID: 68949129467     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Sanyal AJ. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 2002;123:1705-25.
2. Fassio E, Alvarez E, Dominguez N, Landeira G, Longo C. Natural history of nonalcoholic steatohepatitis: a longitudinal study of repeat liver biopsies. Hepatology 2004;40:820-26.
3. Angulo P. Nonalcoholic fatty liver disease: N Engl J Med 2002;346:1221-31.
4. Brunt EM. Nonalcoholic steatohepatitis: definition and pathology: Semin Liver Dis 2001;21:3-16.
5. Caldwell SH, Oelsner DH, Iezzoni JC. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology 1999;29:664-69.
6. Green RM. NASH-hepatic metabolism and not simply the metabolic syndrome. Hepatology 2003;38:14-7.
7. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-53.
8. Tolman KG, Fonseca V, Tan MH, Dalpiaz A. Narrative review: hepatobiliary disease in type 2 diabetes mellitus. Ann Intern Med 2004;21:141:946-56.
9. Roberto De Marco, Francesca Locatelli, Giacomo Zoppini, Giuseppe Verlato, Enzo Bonora, Michele Muggeo. Cause -Specific Mortality in Type 2 Diabetes-The Verona Diabetes Study. Diabetes Care 1999;22:756-61.
10. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, McCullough AJ, Natale S, Forlani G, Melchionda N: Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001;50:1844-50.
11. Elizabeth H Harris. Elevated liver function tests in Type 2 Diabetes. Clinical Diabetes 2005;23:115-9.
12. Freidewald WT, Levy RJ, Fredrickson DS. Estimation of concentration of LDL-C in plasma without use of the preparative ultracentrifuge. Clin Chem 1972;8:499.
13. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999;94:2467-74.
14. Chamukuttan Snehalatha, Vijay Viswanathan, Ambady Ramachandran,: Cutoff values for normal anthropometric variables in Asian Indian adults. Diabetes Care 2003;26: 1380-4.
15. The IDF consensus worldwide definition of the metabolic syndrome, www.idf.org, 2005.
16. Grundt SM, Cleeman JI, Merz CN, et al. Co-ordinating Committee of the National Cholesterol Education Program; National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004;110:227-39.
17. Joseph AE, Saverymuttu SH, al-Sam S, Cook MG, Maxwell JD. Comparison of liver histology with Ultrasonography in assessing diffuse parenchymal liver disease. Clin Radiol 1991;43:26-31
18. Gupte P, Amarapurkar D, Agal S, Baijal R, Kulshrestha P, Pramanik S, Patel N, Madan A, Amarapurkar A, Hafeezunnisa. Non-alcoholic steatohepatitis in type 2 diabetes mellitus. J Gastroenterol Hepatol 2004;19:854-8.
19. Kemmer NM, McKinney KH, Xiao SY, et al. High prevalence of Non-alcoholic steatohepatitis among Mexican American females with type 2 diabetes Mellitus (Abstract). Gastroenterology 2001;120:A117.
20. Angulo P, Keach JC, Batts KP, Lindor KD. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999;30:1356-62.
21. Younossi ZM, Gramlich T, Matteoni CA, Boparai N, McCullough AJ. Nonalcoholic fatty liver disease in patients with type 2 diabetes. Clin Gastroenterol Hepatol 2004;2:262-5.
22. Powell EE, Cooksley WG, Hanson R et al: The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 1990;11:74-80.
23. Mofrad P, Contos MJ, Hague M, et al. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology 2003;37:1286-92.
24. Carmella Loguercio, Vincenzo De Girolamo, Ilario de Sio, Concetta Tuiccillo, Antonio Ascione, Felciano Bald. Non alcoholic fatty liver disease in an area of southern Italy: main clinical, histological, and pathophysiological aspects. J Hepatol 2001;35:568-74.
25. Teli MR, James OFW, Burt AD, Bennett MK, Day CP. The natural history of nonalcoholic fatty liver-a follow-up study. Hepatology 1995;22:1714-19.
26. Bacon BR, Farahvash MJ, Janney CG, Neuschwander-Tetri BA. Nonalcoholic steatohepatitis-an expanded clinical entity. Gastroenterology 1994;107:1103-109.
27. Uygun A, Kadayifci A, Isik AT, et al. Metformin in the treatment of patients with non-alcoholic steatohepatitis. Aliment Pharmacol Ther 2004;19:537-44.
28. Silverman JF, Pories WJ, Caro JF. Liver pathology in diabetes mellitus and morbid obesity: clinical, pathological and biochemical considerations. Pathol Annu 1989;24:275-302.
29. Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A, Angulo P. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005;129:113-21.
30. Camilo Boza, Arnoldo Riquelme, Luis Ibañez, Ignacio Duarte, Enrique Norero, Paola Viviani1, Alejandro Soza, Jose Ignacio Fernandez, Alejandro Raddatz, Sergio Guzman, Marco Arrese. Predictors of Nonalcoholic Steatohepatitis (NASH) in Obese Patients Undergoing Gastric Bypass. Obesity Surgery 2005;15:1148-53.
31. Ong J P, Elariny H, Collantes R, Younoszai A, Chandhoke V, Reines HD, Goodman Z, Younossi ZM: Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients. Obes Surg 2005;15:310-5.
32. Beymer C, Kowdley KV, Larson A, Edmonson P, Dellinger EP, Flum DR: Prevalence and predictors of asymptomatic liver disease in patients undergoing gastric bypass surgery. Arch Surg 2003;138:1240-4.
33. Shimada M, Hashimoto E, Kaneda H, Noguchi S, Hayashi N. Nonalcoholic steatohepatitis: risk factors for liver fibrosis. Hepatol Res 2002;24:429-38.
34. Amarapurkar DN, Amarapurkar AD, Patel ND, Agal S, Baigal R, Gupte P, Pramanik S. Nonalcoholic steatohepatitis (NASH) with diabetes: predictors of liver fibrosis. Ann Hepatol 2006;5:30-3.